Pandemic science
Recently Mr Abdullah Hussain Haroon, former ambassador of Pakistan to the United Nations, came forward with a video recording in which he states that the Covid-19 pandemic is not a natural epidemic but that it was invented in a laboratory as a part of a heinous conspiracy involving Israel, USA and Europe to stop the fast economic development of China.
According to Mr Haroon, a US-based company obtained a patent (No US2006257952) in 2006 of the virus from the US government. However, this information is incorrect as a Google search shows that it has nothing to do with coronavirus but that it was granted to Roche and relates to breast cancer. Similarly according to Mr Haroon, the patent for a vaccine for coronavirus (No EP3172319B1) was applied for in Europe in 2014; and the patent was granted in November 2019. An examination of the patent shows that it is for a vaccine for coronavirus that infects birds and causes symptoms found in bird influenza. It is not for humans.
According to other conspiracy theories, these strains of the coronavirus were accidentally released from US or Chinese laboratories where bioweapons programmes were underway. However, this is mostly conjecture, and there is no solid proof that any of the claims are correct. We may never know the truth.
But conspiracy theories aside, what does science say? The present scientific evidence points to the fact that the virus arose from certain bats in China that contain viruses very similar in structure to that found in Covid-19. One particular bat virus (code named RaTG13), or another virus very similar to it, was most probably the origin. It managed to make two tiny genetic tweaks to its structure that made it so lethal. The first tweak involved allowing it to bind to certain receptors (ACE2) that are present in human cells and that are particularly abundant in human lung cells. This binding is tight, almost perfect, 10 times stronger than what the earlier known SARS virus cells could do.
The second feature that the virus developed was to have a large number of protrusions on its surface that act as tiny harpoons and are able to penetrate into the human lung or other cells when they receive the right signals. The ability of the virus to jump from animals to humans coupled with these two tiny genetic changes has transformed it into a huge global threat to human survival, and it is feared that millions may die before the present storm is over.
In Pakistan we have been so far very lucky that we are not as badly affected as the US and many countries in Europe. The Ministry of Science and Technology has formed a task force to fight against the coronavirus under my chairmanship. The task force has undertaken a number of important initiatives including the procurement and processing for the approval of designs for the manufacture of ventilators needed in hospitals by coronavirus patients. Actual testing and large-scale manufacture could take months which will be too late. Another important initiative is the undertaking of clinical trials at the University of Health Sciences, Lahore and Karachi on some known drugs and anti-viral compounds to determine their efficacy and safety.
A third important project undertaken is the determination of the structure of the strain of coronavirus found in Pakistan. This is being done at the Jamilur Rahman Center for Genomics Research which is an integral part of the Dr Panjwani Center for Molecular Medicine and Drug Research, at the International Center for Chemical and Biological Sciences at University of Karachi. It has been found that the virus has undergone mutations at nine points in its structure as compared to the virus in Wuhan. The implications of these changes are being studied.
The task force is also actively working on the expansion of hospital facilities for coronavirus tests from patients. In this connection, the capacity for daily tests at the Indus Hospital Karachi has already been increased from 800 tests per day to 2400 tests per day through a loan of equipment and technicians installed in the Panjwani Center for Molecular Medicine.
It is vitally important that Pakistan should urgently increase the capacity to carry out 100,000 tests per day. Hundreds of testing facilities should be set up in every neighbourhood of every city with testing done through kits free of charge. We also need to aggressively isolate infected persons and their contacts if we are to contain this menace.
The present testing facilities in the country are pathetic. It is important that the research centers in universities presently under lockdown across Pakistan are immediately allowed to reopen and continue the fight against this deadly virus.
The writer is the former chairman of the HEC, and president of the Network of Academies of Science of OICCountries (NASIC).
Email: [emailprotected]
Recently Mr Abdullah Hussain Haroon, former ambassador of Pakistan to the United Nations, came forward with a video recording in which he states that the Covid-19 pandemic is not a natural epidemic but that it was invented in a laboratory as a part of a heinous conspiracy involving Israel, USA and Europe to stop the fast economic development of China.
According to Mr Haroon, a US-based company obtained a patent (No US2006257952) in 2006 of the virus from the US government. However, this information is incorrect as a Google search shows that it has nothing to do with coronavirus but that it was granted to Roche and relates to breast cancer. Similarly according to Mr Haroon, the patent for a vaccine for coronavirus (No EP3172319B1) was applied for in Europe in 2014; and the patent was granted in November 2019. An examination of the patent shows that it is for a vaccine for coronavirus that infects birds and causes symptoms found in bird influenza. It is not for humans.
According to other conspiracy theories, these strains of the coronavirus were accidentally released from US or Chinese laboratories where bioweapons programmes were underway. However, this is mostly conjecture, and there is no solid proof that any of the claims are correct. We may never know the truth.
But conspiracy theories aside, what does science say? The present scientific evidence points to the fact that the virus arose from certain bats in China that contain viruses very similar in structure to that found in Covid-19. One particular bat virus (code named RaTG13), or another virus very similar to it, was most probably the origin. It managed to make two tiny genetic tweaks to its structure that made it so lethal. The first tweak involved allowing it to bind to certain receptors (ACE2) that are present in human cells and that are particularly abundant in human lung cells. This binding is tight, almost perfect, 10 times stronger than what the earlier known SARS virus cells could do.
The second feature that the virus developed was to have a large number of protrusions on its surface that act as tiny harpoons and are able to penetrate into the human lung or other cells when they receive the right signals. The ability of the virus to jump from animals to humans coupled with these two tiny genetic changes has transformed it into a huge global threat to human survival, and it is feared that millions may die before the present storm is over.
In Pakistan we have been so far very lucky that we are not as badly affected as the US and many countries in Europe. The Ministry of Science and Technology has formed a task force to fight against the coronavirus under my chairmanship. The task force has undertaken a number of important initiatives including the procurement and processing for the approval of designs for the manufacture of ventilators needed in hospitals by coronavirus patients. Actual testing and large-scale manufacture could take months which will be too late. Another important initiative is the undertaking of clinical trials at the University of Health Sciences, Lahore and Karachi on some known drugs and anti-viral compounds to determine their efficacy and safety.
A third important project undertaken is the determination of the structure of the strain of coronavirus found in Pakistan. This is being done at the Jamilur Rahman Center for Genomics Research which is an integral part of the Dr Panjwani Center for Molecular Medicine and Drug Research, at the International Center for Chemical and Biological Sciences at University of Karachi. It has been found that the virus has undergone mutations at nine points in its structure as compared to the virus in Wuhan. The implications of these changes are being studied.
The task force is also actively working on the expansion of hospital facilities for coronavirus tests from patients. In this connection, the capacity for daily tests at the Indus Hospital Karachi has already been increased from 800 tests per day to 2400 tests per day through a loan of equipment and technicians installed in the Panjwani Center for Molecular Medicine.
It is vitally important that Pakistan should urgently increase the capacity to carry out 100,000 tests per day. Hundreds of testing facilities should be set up in every neighbourhood of every city with testing done through kits free of charge. We also need to aggressively isolate infected persons and their contacts if we are to contain this menace.
The present testing facilities in the country are pathetic. It is important that the research centers in universities presently under lockdown across Pakistan are immediately allowed to reopen and continue the fight against this deadly virus.
The writer is the former chairman of the HEC, and president of the Network of Academies of Science of OICCountries (NASIC).
Email: [emailprotected]
Follow this link:
Pandemic science - The News International
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]